Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

(NQ: )

N/A UNCHANGED
Last Price Updated: Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Apricus Biosciences Announces Sale of Ex-U.S. Vitaros Assets and Rights to Ferring Pharmaceuticals
Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that it completed the sale to Ferring International... 
From GlobeNewswire News Releases
Lower close ahead of inauguration
The markets closed lower with the Dow dropping 72 points to 19,732 ahead of the presidential inauguration tomorrow. Nasdaq fell 15 points to 5,540. 
Tags Market News
From MarketMinute.com Market Updates
Lower close ahead of inauguration
The markets closed lower with the Dow dropping 72 points to 19,732 ahead of the presidential inauguration tomorrow. Nasdaq fell 15 points to 5,540. 
Tags Market News
From MarketMinute.com Market Updates
15 Biggest Mid-Day Losers For Thursday
DryShips Inc. (NASDAQ: DRYS) shares dipped 27.7 percent to $1.15. DryShips reported a 1-for-8 reverse stock ... 
Tags SSH X VNOM
From Benzinga
Market approval in Mexico granted to Apricus Biosciences
Mexico granted market approval to Apricus Biosciences Inc.'s (Nasdaq: APRI) erectile dysfunction treatment Vitaros sending the stock price soaring $1.35 to close at $2.86.... 
From MarketMinute.com Stock News
Mid-Afternoon Market Update: Crude Oil Down 2.5%; Gigamon Shares Drop After Issuing Lower Forecast
Toward the end of trading Wednesday, the Dow traded down 0.18 percent to 19,791.90 while the NASDAQ gained 0.06 percent to 5,542.15. ... 
Tags Movers PSO Eurozone
From Benzinga
Apricus Biosciences Inc (APRI) Stock Scores Win on Vitaros Approval
 
Tags NASDAQ:APRI Market Insight, Financial Articles
From InvestorPlace
15 Biggest Mid-Day Gainers For Wednesday
Apricus Biosciences Inc (NASDAQ: APRI) shares jumped 92.7 percent to $2.89 after the company reported the approval of Vitaros in ... 
Tags LIFE GLBS APOP
From Benzinga
Mid-Day Market Update: CoLucid Jumps On Acquisition News; Pearson Shares Tumble
Midway through trading Wednesday, the Dow traded down 0.04 percent to 19,818.57 while the NASDAQ gained 0.12 percent to 5,545.18. The ... 
Tags Guidance Markets CCJ
From Benzinga
Mid-Morning Market Update: Markets Mixed; Goldman Sachs Profit Beats Views
Following the market opening Wednesday, the Dow traded down 0.11 percent to 19,804.87 while the NASDAQ gained 0.23 percent to ... 
Tags GS M&A Benzinga
From Benzinga
Mixed open as CPI edges up
The markets opened mixed with the Dow falling 33 points to 19,793 while Nasdaq rose 14 points to 5,553 as the consumer price index edged up 0.3% in December. 
Tags Market News
From MarketMinute.com Market Updates
Innovus Pharma Expands its Executive Management Team with the Addition of Randy Berholtz as its Executive Vice President, Corporate Development and General Counsel
Innovus Pharma Expands its Executive Management Team with the Addition of Randy Berholtz as its Executive Vice President, Corporate Development and General Counsel 
From Business Wire News Releases
Randy Berholtz Appointed to Hispanica International Delights of America, Inc. Board of Directors
From GlobeNewswire News Releases
Apricus Biosciences Promotes Mary Naggs to Vice President, General Counsel
Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that Mary Naggs has been promoted to Vice President,... 
From GlobeNewswire News Releases
Markets soar ahead of Fed rate decision
The markets soared to close sharply higher with the Dow surging 114 points to 19,911 even as the Federal Reserve is expected to raise interest rates tomorrow. Nasdaq climbed 51 points to 5,463. 
Tags Market News
From MarketMinute.com Market Updates
18 Biggest Mid-Day Losers For Friday
Wins Finance Holdings Inc (NASDAQ: WINS) shares tumbled 43.8 percent to $80.00. Wins Finance shares have jumped ... 
Tags ASYS VRTV MTL
From Benzinga
Mid-Morning Market Update: Markets Mostly Flat; Foot Locker Profit Beats Estimates
Following the market opening Friday, the Dow traded up 0.03 percent to 18,909.00 while the NASDAQ gained 0.03 percent ... 
Tags Commodities ANF Eurozone
From Benzinga
Apricus Biosciences Provides Corporate Update and Third Quarter Financial Results
Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today reported financial results for the third quarter of 2016 and... 
From GlobeNewswire News Releases
18 Biggest Mid-Day Losers For Wednesday
Adeptus Health Inc (NYSE: ADPT) shares declined 66 percent to $9.15 after the company posted downbeat quarterly ... 
Tags ADPT CEMP PAYC
From Benzinga
Stocks Hitting 52-Week Lows
Apricus Biosciences Inc (NASDAQ: APRI) shares fell 10.7 percent to touch a new 52-week low of $1.67. Apricus ... 
Tags Intraday Update Markets MYGN
From Benzinga
Drug Makers Stocks Under Scanner -- Pernix Therapeutics, Novo Nordisk, Synergy Pharma, and Apricus Biosciences
From PR Newswire
BRIEF-Apricus Biosciences announces 1-for-10 reverse stock split
* Apricus Biosciences Inc - reverse stock split will be effective at 5:00 p.m. Pacific time on October 21, 2016 Source text for Eikon: Further company coverage: ;)) 
Tags companyNews
From Reuters: Company News
Apricus Biosciences Announces 1-for-10 Reverse Stock Split
Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced a reverse stock split of its shares of common stock at a... 
From GlobeNewswire News Releases
Apricus Biosciences to Present at the 2016 BIO Investor Forum
Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that Richard Pascoe, Chief Executive Officer, will... 
From GlobeNewswire News Releases
BRIEF-Anson Funds Management LP reports a passive stake of 7 percent in Apricus Biosciences
* Anson Funds Management LP reports a passive stake of percent in Apricus Biosciences Inc as of September 28, 2016 - SEC filing Source text for Eikon: Further company coverage: 
Tags companyNews
From Reuters: Company News
Apricus Biosciences Closes $3.7 Million Registered Direct Offering
Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that it has closed a registered direct offering of... 
From GlobeNewswire News Releases
BRIEF-Apricus Biosciences and certain investors mutually agreed to terminate certain securities purchase agreement
* On Sept 27, co and certain investors mutually agreed to terminate certain securities purchase agreement, dated Sept 22 
Tags companyNews
From Reuters: Company News
BRIEF-Apricus Biosciences to issue about 13.1 mln shares at $0.35 per share
* Apricus Biosciences announces $4.6 million registered direct offering 
Tags companyNews
From Reuters: Company News
Apricus Biosciences Announces $4.6 Million Registered Direct Offering
Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that it has entered into a definitive agreement with... 
From GlobeNewswire News Releases
Apricus Biosciences Announces the Launch of Vitaros® in the Czech Republic and Slovakia by Recordati
Continued Commercial Expansion in Europe Expected to Increase Royalty Revenue for Apricus 
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.